Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter

Severn Trent CEO Liv Garfield speaking at the Hardman & Co Investor Forum Watch Now

Severn Trent CEO Liv Garfield speaking at the Hardman & Co Investor Forum
TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake


Summit Ther Share Chat (SUMM)



Share Price: 23.75Bid: 22.50Ask: 25.00Change: 0.00 (0.00%)No Movement on Summit Ther
Spread: 2.50Spread as %: 11.11%Open: 23.75High: 23.75Low: 23.75Yesterday’s Close: 23.75


Share Discussion for Summit Ther


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

stew200
Posts: 11,307
Opinion:Strong Buy
Price:23.75
Plenty of buys on Nasdaq
Fri 22:19
Seems to be firming ready for a
Surge higher. There is astronomical upside here over the coming few years and this weeks news has been fantastic !
 
PharmaGiles
Posts: 43
Opinion:No Opinion
Price:23.75
Some positive antibiotic news
Thu 19:33
PharmaGiles
Posts: 43
Opinion:No Opinion
Price:23.75
RE: AGM Update
Thu 19:14
Thank you Chris and Waterloo01...

I had a quick look at the DISARM 2019 act again and, on my quick read, it looked like it was effective (after public consultation) on the 1st of Oct 2020 - and providing 106% now, instead of 102%. I might have misunderstood it though? Link to the bill below..

https://www.isakson.senate.gov/public/_cache/files/244e41a8-9d38-4024-9783-a1511c133816/06-04-19%20DISARM%20116th%20Congress.pdf
Chrisatrdg
Posts: 1,531
Opinion:Strong Buy
Price:23.75
AGM Update
19 Jun '19
Per waterloo01 from the other board:
Quick AGM update.

Lots of talk about the different approach to antibiotics, in going for both superiority and presenting the economic case. Many of the recent failures in the space have a lot to do with the fact most are going for equivalence/me too products.

There are only 8 antibiotics currently in phase 1-3 that are new mechanism if actions, RDZ being one of them

Are about 100 sites currently open (Clinical trials lists 2 but apparently is out of date). Results still planned mid 2021.

Barda relationship is good and possibility of some more from them but there is a funding gap which is estimated to be between $60m and $100m over 2 years.

Most likely this will be raised from equity and one has the feeling they have somethings lined up. Stressed point that last placing was at a premium, so hopefully that's repeated. Dungan continues to be supportive and likely to come in on any further raises.

Push and pull incentives are important, but because of their approach (superiority)they will build an economic case regardless. However the current bill going through US congress (Disarm) could make a massive difference as will pay hospital 102% of the cost of the drug (are other initiatives ongoing as well). Might this be the thing that will change the whole investment environment?

Still suggesting market could be worth $1bn US alone (they want to keep US rights but might other geographies be part of any funding?) and if adopted RDZ should save hospitals $3 bn a year.

Other antibiotics all going to plan.

So in short, an exciting future but further funding needed, but the end prize remains significant and ever more so as and when the investing community start to reinvest in the area (and Disarm act might be the thing that makes the difference here).

More if I remember. Good to meet the other investors.
Merlin0
Posts: 203
Opinion:No Opinion
Price:23.75
Summ
19 Jun '19
I thought that this bit of news about additional funds would have put a rocket on the share price?Good old aim
Merlin0
Posts: 203
Opinion:No Opinion
Price:23.75
Summ
19 Jun '19
What other news on the horizon??
Merlin0
Posts: 203
Opinion:No Opinion
Price:23.75
Summ
19 Jun '19
Boom times ahead
Nice rns yesterday
Hawkander
Posts: 599
Opinion:No Opinion
Price:25.00
Buy?
18 Jun '19
Any thoughts of a potential buyout by one of the majors, with what`s on offer here at this stage, just a thought? GLA
Ollieh
Posts: 4,921
Opinion:No Opinion
Price:25.00
RE: SUMM
18 Jun '19
Looking good again now hopefully.
PharmaGiles
Posts: 43
Opinion:No Opinion
Price:25.00
RE: Phase 3 results
18 Jun '19
RNS 12th June

"Recruitment of patients into the two Phase 3 clinical trials is ongoing, and the programme remains on-track for expected reporting of top-line data in H2 2021"...

We should get more updates on recruitment as the trial progresses.. - I'd hope at least
Chipmunk1
Posts: 6
Opinion:No Opinion
Price:25.00
RE: Phase 3 results
18 Jun '19
Perhaps should also mention as phase 3 results sound a while away but there will be news on other products in the pipeline currently on there Discuva platform.
GLA
Chipmunk1
Posts: 6
Opinion:No Opinion
Price:25.00
RE: Phase 3 results
18 Jun '19
Hi Stew200 Should be early 2021 although they have fast track status so hopefully earlier (-;
GLA
stew200
Posts: 11,307
Opinion:No Opinion
Price:25.00
Phase 3 results
18 Jun '19
When will they be posted ?
Sheephatch
Posts: 1,350
Opinion:No Opinion
Price:25.00
SUMM
18 Jun '19
Yes good news today and long term a truly terrific opportunity. Perhaps we might even see our DMD losses back. Keep the faith. Good luck.
Hawkander
Posts: 599
Opinion:No Opinion
Price:25.00
RE:News
18 Jun '19
The RNS was certainly positive and the US seem to have great confidence in the science, so fingers crossed for a decent move North, especially for the people who need this to work and SH`s alike. GLA
Nibbers
Posts: 1
Opinion:No Opinion
Price:25.00
RE: News
18 Jun '19
i would like to hope we can get back to the levels we were at last year before the crash, however i can't see it happening , i think like most on here i'm in a catch 22 position, can't afford to buy anymore and just looking to make the best of a very bad investment, damage limitation and a long few years ahead.
Hawkander
Posts: 599
Opinion:No Opinion
Price:25.00
News
18 Jun '19
I wonder if we can get to the levels we got to a few years ago and are we expecting more news.
Chrisatrdg
Posts: 1,531
Opinion:Strong Buy
Price:25.00
The Elephant in the room
18 Jun '19
I think todays RNS may have got rid of 'The Elephant in the room' i.e. future funding & for the first the SP continues to rise (no profit taking).I only wish I had the funds to top up.
stew200
Posts: 11,307
Opinion:Strong Buy
Price:23.75
RE: The next RNS
18 Jun '19
Agreed great call shows really re-emphasises how likely this is to succeed now! The sky is the limit here
Bermudashorts
Posts: 10,052
Opinion:No Opinion
Price:23.75
RE: The next RNS
18 Jun '19
yep, good call Christatrdg
Chrisatrdg
Posts: 1,531
Opinion:Strong Buy
Price:23.00
RE: The next RNS
18 Jun '19
Well looks like my gut feeling Monday was right ( see below) todays RNS is great news & demonstrates that there is additional support for the Phase 3 C-Diff trials which should extend the cash runway.
Monday post:
'Could we be in for a surprise RNS soon in which it is announced that Summit will receive further funding for their C-Diff trials based on recent articles for the need to combat diseases like C-Diff there was a final realisation that their drug must succeed & so funds provided.Just a thought.'
stew200
Posts: 11,307
Opinion:No Opinion
Price:22.50
SUMM
18 Jun '19
That’s greats news
Bermudashorts
Posts: 10,052
Opinion:No Opinion
Price:22.25
SUMM
18 Jun '19
'Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces that the Biomedical Advanced Research and Development Authority (‘BARDA’) has increased the total value of its award for the clinical and regulatory development of Summit’s precision antibiotic ridinilazole for the treatment of C. difficile infection (‘CDI’) to up to $63.7 million.'

http://www.globenewswire.com/news-release/2019/06/18/1870133/0/en/Increased-BARDA-Award-and-Option-Exercise.html
PharmaGiles
Posts: 43
Opinion:No Opinion
Price:21.25
RE: The next RNS
17 Jun '19
Thanks Chris - look forward to hearing how it goes, and as you say they can't really give any substantial updates without an RNS... hopefully we'll start seeing a recovery soon..




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk







Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.